Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-02T01:30:17.897Z Has data issue: false hasContentIssue false
  • English
  • Français

Maternal prevalence of toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis

Published online by Cambridge University Press:  15 May 2009

A. E. Ades ,
S. Parker ,
R. Gilbert ,
P. A. Tookey ,
T. Berry ,
M. Hjelm ,
A. H. Wilcox ,
D. Cubitt  and
C. S. Peckham
A. E. Ades*
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
S. Parker
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
R. Gilbert
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
P. A. Tookey
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
T. Berry
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
M. Hjelm
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
A. H. Wilcox
Affiliation:
Neonatal Screening Laboratory, St Helier Hospital, Carshalton
D. Cubitt
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
C. S. Peckham
Affiliation:
Epidemiology and Biostatistics Unit, Department of Virology, and Department of Clinical Biochemistry, Institute of Child Health and Hospitals for Sick Children
*
*Dr A. E. Ades. Epidemiology and Biostatistics Unit. Institute of Child Health. 30 Guilford Street. London WC1N.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A total of 12902 neonatal samples collected on absorbent paper for routine metabolic screening were tested anonymously for antibodies to toxoplasma. Seroprevalence varied from 19.5% in inner London, to 11.6% in suburban London, and 7.6% in non-metropolitan districts. Much of this variation appeared to be associated with the proportions of livebirths in each district to women born outside the UK. However, additional geographical variation remained and seroprevalence in UK-born women was estimated to be 12.7% in inner London, 7.5% in suburban London, and 5.5% in non-metropolitan areas. These estimates are considerably lower than any previously reported in antenatal sera in the UK. The wide geographical variation highlights a need for further research to determine the relative importance of different routes of transmission.

Type
Research Article
Information
Epidemiology & Infection , Volume 110 , Issue 1 , February 1993 , pp. 127 - 133
Copyright
Copyright © Cambridge University Press 1993

References

REFERENCES

1.Remington, JS, Desmonts, G. Toxoplasmosis. In: Remington, JS, Klein, JO. eds. Infectious diseases of the fetus and newborn infant. 3rd ed. Philadelphia: W B Saunders. 1990: 89–195.Google Scholar
2.Ades, AE. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect 1992: 108: 367–75.CrossRefGoogle ScholarPubMed
3.Peckham, CS. Tedder, RS. Briggs, M. Ades, AE. Hjelm, M. Wilcox, AH. Parra-Mejia, N. O'Conner, C. Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet 1990: 335: 516–9.CrossRefGoogle ScholarPubMed
4.Parker, SP. Cubitt, WD. A modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards. J Clin Pathol 1992: 45: 907–9.CrossRefGoogle ScholarPubMed
5.Peckham, CS. Chin, KS. Coleman, JC. Henderson, K. Hurley, Y. Preece, PM. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet 1983; i: 1352–5.CrossRefGoogle Scholar
6.Cubitt, WD. Ades, AE. Peckham, CS. Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol 1992; 45: 435–8.CrossRefGoogle ScholarPubMed
7.Wacholder, S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986; 123: 174–84.CrossRefGoogle ScholarPubMed
8.Ruoss, CF. Bourne, GL. Toxoplasmosis in pregnancy. J Obstet Gynaecol British Commonwealth 1972; 79: 1115–18.CrossRefGoogle ScholarPubMed
9.Williams, KAB. Scott, JM. MacFarlane, DE. Williamson, JMW, Elias-Jones, TF. Williams, H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect 1981; 3: 219–29.CrossRefGoogle ScholarPubMed
10.Walker, J. Nokes, DJ. Jennings, R. Longitudinal study of toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect 1992; 108: 99–106.CrossRefGoogle ScholarPubMed
11.Forsgren, M. Gille, E. Ljungstrom, I. Nokes, DJ. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969. 1979, and 1987. Lancet 1991: 337: 1413–14.CrossRefGoogle ScholarPubMed
12.Haskey, J. The ethnic minority populations resident in private households – estimates by country and metropolitan district of England and Wales. Reproduction Trends 1991; 63: 22–35.Google Scholar